ArticleOncotarget2016

Morphoproteomics and biomedical analytics confirm the mTORC2/Akt pathway as a resistance signature and activated ERK and STAT3 as concomitant prosurvival/antiapoptotic pathways in metastatic renal cell carcinoma (RCC) progressing on rapalogs: pathogenesis and therapeutic options.

Robert E Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.